Common side effects include: Injection site reactions mild pain, redness, swelling, or bruising at the injection site, typically resolving within a few days Headache usually transient and manageable with standard analgesia Nausea or dizziness particularly in the initial treatment phase Skin reactions including itching, mild rash, or acneiform eruptions Temporary urine discolouration red or orange urine is harmless and expected Diarrhoea or flushing usually mild and self-limiting In patients with severe megaloblastic anaemia, low potassium levels (hypokalaemia) may occur during initial intensive treatment, but this is uncommon in routine maintenance therapy

Australia-wide dispatch Australia Post Express tracked 12 business days Research-grade COA-verified HPLC purity data manufacturer CoA Crypto payment BTC LTC XMR researcher privacy by design RetaLABS BPC-157 / TB-500 Blend combines two of the most researched tissue-repair peptides into a single lyophilised vial, providing 5mg BPC-157 and 5mg TB-500 (Thymosin Beta-4 fragment) per vial
Nature Reviews Endocrinology, 13(4), 220-231
Optimal Protocol for Body Recomposition Results Establishing an effective Retatrutide protocol for body recomposition requires balancing efficacy against tolerability while supporting the metabolic environment needed for optimal results